PITTSBURGH--(BUSINESS WIRE)--Helomics™ Corporation, a privately-held comprehensive personalized healthcare company that provides comprehensive tumor profiling utilizing proprietary live cell and fixed cell products and services, announced today that the Company is scheduled to present at the BioCentury Future Leaders in the Biotech Industry Conference taking place in New York City at the Millennium Broadway Hotel on March 20, 2015. Neil J. Campbell, President and Chief Executive Officer of Helo
| < Prev | Next > |
|---|
